androstenedione has been researched along with Sepsis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barr, BS; Burns, TA; David, B; Dembek, KA; Hart, KA; Johnson, LM; Timko, KJ; Toribio, RE | 1 |
| Bland, KI; Chaudry, IH; Cioffi, WG; Nickel, EA; Samy, TS; Schneider, CP; Schwacha, MG | 1 |
2 other study(ies) available for androstenedione and Sepsis
| Article | Year |
|---|---|
Steroids, steroid precursors, and neuroactive steroids in critically ill equine neonates.
Topics: Adrenocorticotropic Hormone; Androstenedione; Animals; Animals, Newborn; Critical Illness; Horse Diseases; Horses; Hydrocortisone; Hypothalamic Diseases; Hypothalamo-Hypophyseal System; Pituitary-Adrenal System; Pregnenolone; Progesterone; Prognosis; Sepsis; Steroids | 2017 |
The aromatase inhibitor, 4-hydroxyandrostenedione, restores immune responses following trauma-hemorrhage in males and decreases mortality from subsequent sepsis.
Topics: Androstenedione; Animals; Aromatase Inhibitors; Cytokines; Enzyme Inhibitors; Estrogen Receptor alpha; Estrogen Receptor beta; Male; Mice; Mice, Inbred C3H; Receptors, Androgen; Receptors, Estrogen; Resuscitation; Sepsis; Shock, Hemorrhagic; Spleen; Survival Rate; Th1 Cells; Wounds and Injuries | 2000 |